Article Details

Cellectis (NASDAQ:CLLS) Downgraded by Zacks Investment Research

Retrieved on: 2018-02-25 04:48:45

Tags for this article:

Click the tags to see associated articles and topics

Cellectis (NASDAQ:CLLS) Downgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> LLC grew its position in shares of Cellectis by 1,356.2% in the 4th quarter. <b>Millennium Management</b> LLC now owns 104,290 shares of the biotechnology company's stock valued at $3,040,000 after acquiring an additional 97,128 shares during the period. Finally, Bain Capital ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo